跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BIOTHRAX - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
BIOTHRAX
Authorized
STANDARD
BIOTHRAX
Emergent Biodefense Operations Lansing LLC
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
2bb3136f3c102783
Company
Emergent Biodefense Operations Lansing LLC
Type
Standard
Approval Details
Approval Id
2bb3136f3c102783
Drug Approval Canada Name
BIOTHRAX
Product Name
BIOTHRAX
Status
Restricted Access
Status Date
2019-03-20
Din
02483386
Drug Class
Human
Dosage Form
Suspension
Route Of Administration
Intramuscular , Subcutaneous
Schedule
Schedule D
Ahfs
80:12.00
Atc Original
J07AC01 ANTHRAX ANTIGEN
Atc Name
j 07 ac 01
Aig Number
0161010001
Company Name
Emergent Biodefense Operations Lansing LLC
Company Address
3500 N. Martin Luther King Jr. Blvd., Lansing, Michigan, United States, 48906
Company Detail Path
/organization/emergent-biodefense-operations-lansing-llc
Company Information
Pharmaceutical Company Name
Emergent Biodefense Operations Lansing LLC
Country Name
United States
Province Name
密歇根州
Active Ingredients
ANTHRAX ANTIGEN FILTRATE
50 MCG / 0.5 ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
2bb3136f3c102783
Type
Standard
Back to Health Canada Approvals